Phio stock today
Webb9 juli 2024 · InvestorsObserver’s proprietary ranking system, gives PHIO stock a score of 5 out of a possible 100. That rank is influenced by a fundamental score of 0. PHIO stock has a mean target price of 9. This means analysts expect the stock to increase 254.33% over the next 12 months. PHIO's rank also includes a long-term technical score of 2. Webb3 apr. 2024 · Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its …
Phio stock today
Did you know?
Webb22 feb. 2024 · Phio Pharmaceuticals Corp., a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1- for-12. WebbPHIO - Phio Pharmaceuticals Corp. - Stock screener for investors and traders, financial visualizations. Home: News: Screener: Maps: Groups: ... 3 Hot Penny Stocks: Why …
WebbFör 1 dag sedan · 00:00. 01:02. Bud Light’s controversial marketing deal with transgender social media influencer Dylan Mulvaney has ignited speculation that top executives at … Webb14 sep. 2024 · PHIO Stock Price Today Phio Pharmaceuticals Corp. ( PHIO) stock rallied over 1.60% intraday to trade at $0.6909 a share on NASDAQ. The stock opened with a loss of -9.09% at $ 0.737 and touched an intraday high of $ 0.738, falling -6.89% against the last close of $ 0.742. The stock went to a low of $ 0.68 during the session. Stock Snapshot $ …
Webbför 18 timmar sedan · Today's big story: Earnings season has kicked up a gear with reports from several big banks including JPMorgan, which posted record quarterly revenue. … WebbGet the latest Phio Pharmaceuticals Corp (PHIO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Webb20 feb. 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology is designed to make immune cells more effective in killing tumor cells. INTASYL is the only self-delivering RNAi technology focused on immuno-oncology therapeutics.
WebbPhio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA. CEO Robert J. Bitterman Employees 9 Headquarters Marlborough, Massachusetts Founded 2011 PHIO Key Statistics Market … increase conversions and start selling moreWebb8 apr. 2024 · Phio Pharmaceuticals Corp. ... therapeutic platform, today presented positive new preclinical data showing PH-894, ... Watch JPMorgan and these bank stocks. increase conversions on websiteWebbPhio Pharmaceuticals Corp. (PHIO) Stock Price, News, Quote & History - Yahoo Finance My Portfolio Crypto U.S. markets open in 5 hours 38 minutes Dow Futures (-0.01%) Nasdaq … increase controller sensitivity pcWebbPhio Pharmaceuticals Corp. (PHIO) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 5.71 +0.11 (+1.96%) At close: 03:57PM EDT Summary Company Insights Chart Conversations... increase copying speed windows 10WebbPhio Pharmaceuticals Corp. (PHIO) Latest Stock News & Headlines - Yahoo Finance Dow Futures -41.00 Phio Pharmaceuticals Corp. (PHIO) NasdaqCM - NasdaqCM Real Time … increase copper intakeWebb11 apr. 2024 · Ticker Symbol PHIO Full Company Profile Financial Performance Financial Statements Analyst Forecast According to 7 analysts, the average rating for PHIO stock … increase copy speed windows 11WebbPhio Pharmaceuticals Corp (PHIO) Stock Price Today, News, Quotes, FAQs and Fundamentals 8.50% KRYS 4.70% INFY 0.46% FAST 0.66% UNL 3.55% More … increase corn yield